Advertisement

Journal of Regulatory Economics

, Volume 55, Issue 3, pp 258–281 | Cite as

Does the ban on trans-fats improve public health? In search of the optimal policy response

  • Mitja KovacEmail author
  • Rok Spruk
Original Article
  • 102 Downloads

Abstract

This paper examines the contribution of the regulatory ban on trans-fats and voluntary trans-fat regulation to public health outcomes for a sample of 39 countries in the period 1990–2015. To this end, we exploit within-country variation in trans-fat legislation to estimate the impact of the trans fat ban on cardiovascular mortality and obesity rates. Our difference-in-difference estimates indicate modest and beneficial effects of the trans-fats ban in reducing cardiovascular mortality and obesity rate. We find that the ban on trans fats tends to decrease the mortality rate attributed to cardiovascular diseases while the effects on the obesity rates are significant, especially among children and adolescent age group. By contrast, voluntary regulation of trans fats and demand-driven regulatory strategies are generally not associated with a marked drop in the obesity rate. By controlling for country-specific time trends, we show that the estimated mortality- and obesity-related impact of the ban is not driven by pre-existing trends, and does not affect non-cardiovascular mortality rate.

Keywords

Trans-fats Empirical legal studies Public policy Public health 

JEL Classification

C23 C26 C51 K42 O43 

Notes

References

  1. Arellano, M., & Bond, S. (1991). Some tests of specification for panel data: Monte Carlo evidence and an application to employment equations. The Review of Economic Studies, 58(2), 277–297.CrossRefGoogle Scholar
  2. Aro, A., Jauhiainen, M., Partanen, R., Salminen, I., & Mutanen, M. (1997). Stearic acid, trans fatty acids, and dairy fat: Effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein (a), and lipid transfer proteins in healthy subjects. The American Journal of Clinical Nutrition, 65(5), 1419–1426.CrossRefGoogle Scholar
  3. Ascherio, A., Hennekens, C. H., Buring, J. E., Master, C., Stampfer, M. J., & Willett, W. C. (1994). Trans-fatty acids intake and risk of myocardial infarction. Circulation, 89(1), 94–101.CrossRefGoogle Scholar
  4. Ascherio, A., & Willett, W. C. (1997). Health effects of trans fatty acids. The American Journal of Clinical Nutrition, 66(4), 1006S–1010S.CrossRefGoogle Scholar
  5. Astrup, A., Dyerberg, J., Selleck, M., & Stender, S. (2008). Nutrition transition and its relationship to the development of obesity and related chronic diseases. Obesity Reviews, 9(s1), 48–52.CrossRefGoogle Scholar
  6. Baer, D. J., Judd, J. T., Clevidence, B. A., & Tracy, R. P. (2004). Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: A randomized crossover study. The American Journal of Clinical Nutrition, 79(6), 969–973.CrossRefGoogle Scholar
  7. Besley, T., & Burgess, R. (2004). Can labor regulation hinder economic performance? Evidence from India. Quarterly Journal of Economics, 119(1), 91–134.CrossRefGoogle Scholar
  8. Brouwer, I. A., Wanders, A. J., & Katan, M. B. (2013). Trans fatty acids and cardiovascular health: Research completed? European Journal of Clinical Nutrition, 67(5), 541–547.CrossRefGoogle Scholar
  9. Brownell, K. D., & Pomeranz, J. L. (2014). The trans-fat ban—Food regulation and long-term health. New England Journal of Medicine, 370(19), 1773–1775.CrossRefGoogle Scholar
  10. Caggiula, A. W., & Mustad, V. A. (1997). Effects of dietary fat and fatty acids on coronary artery disease risk and total and lipoprotein cholesterol concentrations: Epidemiologic studies. The American Journal of Clinical Nutrition, 65(5), 1597S–1610S.CrossRefGoogle Scholar
  11. Cameron, A. C., Gelbach, J. B., & Miller, D. L. (2011). Robust inference with multiway clustering. Journal of Business & Economic Statistics, 29(2), 238–249.CrossRefGoogle Scholar
  12. Cohen, J. T. (2014). FDA’s proposed ban on trans fats: How do the costs and benefits stack up? Clinical Therapeutics, 36(3), 322–327.CrossRefGoogle Scholar
  13. Coombes, R. (2011). Trans fats: Chasing a global ban. British Medical Journal (BMJ), 343, d5567.CrossRefGoogle Scholar
  14. Danaei, G., Ding, E. L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C. J., et al. (2009). The preventable causes of death in the United States: Comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Medicine, 6(4), e1000058.CrossRefGoogle Scholar
  15. De Geest, G., & Kovac, M. (2009). Formation of contracts in the draft common frame of reference. European Review of Private Law, 17(2), 113.Google Scholar
  16. Downs, S. M., Thow, A. M., & Leeder, S. R. (2013). The effectiveness of policies for reducing dietary trans fat: A systematic review of the evidence. Bulletin of the World Health Organization, 91(4), 262–269h.CrossRefGoogle Scholar
  17. Ebbeling, C. B., Pawlak, D. B., & Ludwig, D. S. (2002). Childhood obesity: Public-health crisis, common sense cure. The Lancet, 360(9331), 473–482.CrossRefGoogle Scholar
  18. Farrell, J. (1986). Voluntary disclosure: Robustness of the unraveling result, and comments on its importance. In R. Grieson (Ed.), Antitrust and regulation. Lanham: Lexington Books.Google Scholar
  19. Feenstra, R. C., Inklaar, R., & Timmer, M. P. (2015). The next generation of the Penn World Table. American Economic Review, 105(10), 3150–3182.CrossRefGoogle Scholar
  20. Fishman, J. M., & Hagerty, M. K. (1990). The optimal amount of discretion to allow in disclosure. Quarterly Journal of Economics, 105(2), 427–444.CrossRefGoogle Scholar
  21. Golombieski, R., Veit, J. C., Piccolo, J., Emanuelli, T., Rocha, J. B. T., & Bürger, M. E. (2015). Cross-generational trans fat intake modifies BDNF mRNA in the hippocampus: Impact on memory loss in a mania animal model. Hippocampus, 25(5), 556–565.CrossRefGoogle Scholar
  22. Gould, E., Tanapat, P., McEwen, B. S., Flügge, G., & Fuchs, E. (1998). Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proceedings of the National Academy of Sciences, 95(6), 3168–3171.CrossRefGoogle Scholar
  23. Grossman, J. S. (1981). The informational role of warranties and private disclosure about product quality. Journal of Law and Economics, XXIV, 461–489.CrossRefGoogle Scholar
  24. Han, S. N., Leka, L. S., Lichtenstein, A. H., Ausman, L. M., Schaefer, E. J., & Meydani, S. N. (2002). Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. Journal of Lipid Research, 43(3), 445–452.Google Scholar
  25. Hayek, F. A. (1973). Law, legislation and liberty. London: Routledge.Google Scholar
  26. Hendry, V. L., Almíron-Roig, E., Monsivais, P., Jebb, S. A., Benjamin Neelon, S. E., Griffin, S. J., et al. (2015). Impact of regulatory interventions to reduce intake of artificial trans–fatty acids: A systematic review. American Journal of Public Health, 105(3), e32–e42.CrossRefGoogle Scholar
  27. Hirschleifer, J., & Riley, G. J. (1995). The analytics of uncertainty and information (3rd reprint). Cambridge: Cambridge University Press.Google Scholar
  28. Jovanovic, B. (1982). Truthful disclosure of information. Bell Journal of Economics, 13, 36–44.CrossRefGoogle Scholar
  29. Judd, J. T., Clevidence, B. A., Muesing, R. A., Wittes, J., Sunkin, M. E., & Podczasy, J. J. (1994). Dietary trans fatty acids: Effects on plasma lipids and lipoproteins of healthy men and women. The American Journal of Clinical Nutrition, 59(4), 861–868.CrossRefGoogle Scholar
  30. Katan, M. B., Zock, P. L., & Mensink, R. P. (1995). Trans fatty acids and their effects on lipoproteins in humans. Annual Review of Nutrition, 15(1), 473–493.CrossRefGoogle Scholar
  31. Kavanagh, K., Jones, K. L., Sawyer, J., Kelley, K., Carr, J. J., Wagner, J. D., et al. (2007). Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Obesity, 15(7), 1675–1684.CrossRefGoogle Scholar
  32. Koletzko, B. (1992). Trans fatty acids may impair biosynthesis of long-chain polyunsaturates and growth in man. Acta Paediatrica, 81(4), 302–306.CrossRefGoogle Scholar
  33. Kromhout, D., & De Coulander, C. L. (1984). Diet, prevalence and 10-year mortality from coronary heart disease in 871 middle-aged men: The Zutphen Study. American Journal of Epidemiology, 119(5), 733–741.CrossRefGoogle Scholar
  34. Kronman, A. T. (1978). Mistake, disclosure, information, and the law of contracts. Journal of Legal Studies, 7(1), 1–34.CrossRefGoogle Scholar
  35. Lemaitre, R. N., King, I. B., Raghunathan, T. E., Pearce, R. M., Weinmann, S., Knopp, R. H., et al. (2002). Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation, 105(6), 697–701.CrossRefGoogle Scholar
  36. Leth, T., Jensen, H. G., Mikkelsen, A. Æ., & Bysted, A. (2006). The effect of the regulation on trans fatty acid content in Danish food. Atherosclerosis Supplements, 7(2), 53–56.CrossRefGoogle Scholar
  37. Ludwig, D. S. (2011). Technology, diet, and the burden of chronic disease. Journal of American Medical Association, 305(13), 1352–1353.CrossRefGoogle Scholar
  38. Mackaay, E. (1982). Economics of information and law. Dordrecht: Kluwer Nijhof Publishing.CrossRefGoogle Scholar
  39. Matthews, S., & Postlewaite, A. (1985). Quality testing and disclosure. The Rand Journal of Economics, 16(3), 328–340.CrossRefGoogle Scholar
  40. Mensink, R. P. (2016). Effects of saturated fatty acids on serum lipids and lipoproteins: A systematic review and regression analysis. Geneva: World Health Organization.Google Scholar
  41. Mensink, R. P., & Katan, M. B. (1990). Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. New England Journal of Medicine, 323(7), 439–445.CrossRefGoogle Scholar
  42. Mensink, R. P., Sanders, T. A., Baer, D. J., Hayes, K. C., Howles, P. N., & Marangoni, A. (2016). The increasing use of interesterified lipids in the food supply and their effects on health parameters. Advances in Nutrition, 7(4), 719–729.CrossRefGoogle Scholar
  43. Micha, R., & Mozaffarian, D. (2009). Trans fatty acids: Effects on cardiometabolic health and implications for policy. Prostaglandins Leukot Essent Fatty Acids, 79(3–5), 147–152.Google Scholar
  44. Milgrom, R. P. (1981). Good news and bad news: Representation theorems and applications. Bell Journal of Economics, 12, 380–391.CrossRefGoogle Scholar
  45. Missmer, S. A., Chavarro, J. E., Malspeis, S., Bertone-Johnson, E. R., Hornstein, M. D., Spiegelman, D., et al. (2010). A prospective study of dietary fat consumption and endometriosis risk. Human Reproduction, 25(6), 1528–1535.CrossRefGoogle Scholar
  46. Moulton, B. R. (1986). Random group effects and the precision of regression estimates. Journal of Econometrics, 32(3), 385–397.CrossRefGoogle Scholar
  47. Moulton, B. R. (1990). An illustration of a pitfall in estimating the effects of aggregate variables on micro units. The Review of Economics and Statistics, 72(2), 334–338.CrossRefGoogle Scholar
  48. Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006). Trans fatty acids and cardiovascular disease. New England Journal of Medicine, 354(15), 1601–1613.CrossRefGoogle Scholar
  49. Mozaffarian, D., Rimm, E. B., King, I. B., Lawler, R. L., McDonald, G. B., & Levy, W. C. (2004). Trans fatty acids and systemic inflammation in heart failure. The American Journal of Clinical Nutrition, 80(6), 1521–1525.CrossRefGoogle Scholar
  50. O’Flaherty, M., Flores-Mateo, G., Nnoaham, K., Lloyd-Williams, F., & Capewell, S. (2012). Potential cardiovascular mortality reductions with stricter food policies in the United Kingdom of Great Britain and Northern Ireland. Bulletin of the World Health Organization, 90, 522–531.CrossRefGoogle Scholar
  51. Ogus, A. I. (2004). Regulation: Legal form and economic theory. London: Bloomsbury Publishing.Google Scholar
  52. Oh, K., Hu, F. B., Manson, J. E., Stampfer, M. J., & Willett, W. C. (2005). Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses’ health study. American Journal of Epidemiology, 161(7), 672–679.CrossRefGoogle Scholar
  53. Okuno-Fujiwara, M., Postlewaite, A., & Suzumura, K. (1990). Strategic information revelation. The Review of Economic Studies, 57, 25–47.CrossRefGoogle Scholar
  54. Posner, R. A. (2014). Economic analysis of law (9th ed.). Dordrecht: Kluwer.Google Scholar
  55. Ratnayake, W. M. N., L’abbe, M. R., & Mozaffarian, D. (2009). Nationwide product reformulations to reduce trans fatty acids in Canada: When trans fat goes out, what goes in? European Journal of Clinical Nutrition, 63(6), 808.CrossRefGoogle Scholar
  56. Restrepo, B. J., & Rieger, M. (2016a). Trans fat and cardiovascular disease mortality: Evidence from bans in restaurants in New York. Journal of Health Economics, 45, 176–196.CrossRefGoogle Scholar
  57. Restrepo, B. J., & Rieger, M. (2016b). Denmark’s policy on artificial trans fat and cardiovascular disease. American Journal of Preventive Medicine, 50(1), 69–76.CrossRefGoogle Scholar
  58. Riserus, U. L. F., Arner, P., Brismar, K., & Vessby, B. (2002). Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care, 25(9), 1516–1521.CrossRefGoogle Scholar
  59. Salmeron, J., Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G. A., Rimm, E. B., et al. (2001). Dietary fat intake and risk of type 2 diabetes in women. The American Journal of Clinical Nutrition, 73(6), 1019–1026.CrossRefGoogle Scholar
  60. Schäefer, H. B., & Ott, C. (2004). The economic analysis of civil law. Cheltenham‎: Edward Elgar.Google Scholar
  61. Shavell, S. (1994). Acqusition and disclosure of information prior to sale. The Rand Journal of Economics, 25(1), 20–36.CrossRefGoogle Scholar
  62. Stender, S., & Dyerberg, J. (2003). The influence of trans fatty acids on health. Report from the Danish Nutrition Council. Danish Nutrition Council.Google Scholar
  63. Stender, S., Dyerberg, J., & Astrup, A. (2006). Consumer protection through a legislative ban on industrially produced trans fatty acids in foods in Denmark. Scandinavian Journal of Food and Nutrition, 50(4), 155–160.CrossRefGoogle Scholar
  64. Teegala, S. M., Willett, W. C., & Mozaffarian, D. (2009). Consumption and health effects of trans fatty acids: A review. Journal of AOAC International, 92(5), 1250–1257.Google Scholar
  65. Thaler, R. H., & Sunstein, C. R. (2003). Libertarian paternalism. American Economic Review, 93(2), 175–179.CrossRefGoogle Scholar
  66. Trebilcock, J. M. (1993). The limits of freedom of contract. Cambridge: Harvard University Press.Google Scholar
  67. Trevizol, F., Dias, V. T., Roversi, K., Barcelos, R. C. S., Kuhn, F. T., Roversi, F. T., et al. (2015) Cross-generational transfat intake modifies BDNF mRNA in the hippocampus: impact on memory loss in a mania animal model. Hippocampus, 25, 556–565.CrossRefGoogle Scholar
  68. Uauy, R., Aro, A., Clarke, R., L’Abbé, M. R., Mozaffarian, D., Skeaff, C. M., et al. (2009). WHO scientific update on trans fatty acids: Summary and conclusions. European Journal of Clinical Nutrition, 63(S2), S68.CrossRefGoogle Scholar
  69. Van De Veer, D. (1986). Paternalistic intervention: The moral bounds on benevolence. Princeton: Princeton University Press.Google Scholar
  70. Vandana, D., Gulia, N., Kulveer, S., & Singh Khatkar, B. (2011). Trans fats—Sources, health risks and alternative approach—A review. Journal of Food Science and Technology, 48(5), 534–541.CrossRefGoogle Scholar
  71. Vesper, H. W., Kuiper, H. C., Mirel, L. B., Johnson, C. L., & Pirkle, J. L. (2012). Levels of plasma trans-fatty acids in non-Hispanic white adults in the United States in 2000 and 2009. Journal of American Medical Association, 307(6), 562–563.CrossRefGoogle Scholar
  72. Williams, M. A., King, I. B., Sorensen, T. K., Zingheim, R. W., Troyer, B. L., Zebelman, A. M., et al. (1998). Risk of preeclampsia in relation to elaidic acid (trans fatty acid) in maternal erythrocytes. Gynecologic and Obstetric Investigation, 46(2), 84–87.CrossRefGoogle Scholar
  73. Wonnell, T. C. (1991). The structure of a general theory of non-disclosure. Case Western Research Law Review, 41, 329.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Faculty of EconomicsUniversity of LjubljanaLjubljanaSlovenia

Personalised recommendations